What about pleiotropic modifiers of preprocedural pro-inflammatory and pro-oxidant milieu in patients undergoing drug eluting stent implantation?
The exact pathophysiological mechanisms of coronary in-stent restenosis (ISR) has not yet been fully elucidated. Inflammation is known as the most commonly encountered pathway. Medications for cardiometabolic risk factors as the modifiers of preprocedural pro-inflammatory and pro-oxidant milieu shou...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
KARE Publishing,
2015-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The exact pathophysiological mechanisms of coronary in-stent restenosis (ISR) has not yet been fully elucidated. Inflammation is known as the most commonly encountered pathway. Medications for cardiometabolic risk factors as the modifiers of preprocedural pro-inflammatory and pro-oxidant milieu should be considered in all patients. |
|---|---|
| Item Description: | 1016-5169 10.5543/tkda.2015.85055 |